Ashburton (Jersey)’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,942
Closed -$2.93M 59
2023
Q1
$2.93M Buy
3,942
+3,272
+488% +$267K 1.36% 17
2022
Q4
$83K Sell
670
-3,411
-84% -$276K 0.05% 32
2022
Q3
$1.13M Buy
4,081
+3,876
+1,891% +$348K 0.67% 20
2022
Q2
$46K Sell
205
-1,408,454
-100% -$143M 0.02% 37
2022
Q1
$24.1M Buy
+1,408,659
New +$149M 9.61% 3
2020
Q4
Sell
-109
Closed -$12K 87
2020
Q3
$12K Hold
109
0.01% 59
2020
Q2
$12K Sell
109
-5,531
-98% -$530K 0.01% 59
2020
Q1
$184K Hold
5,640
0.09% 30
2019
Q4
$221K Buy
+5,640
New +$619K 0.09% 30
2019
Q3
Sell
-54,280
Closed -$2.35M 107
2019
Q2
$2.35M Buy
54,280
+54,020
+20,777% +$4.93M 1.12% 12
2019
Q1
$16K Sell
260
-5,550
-96% -$497K 0.01% 52
2018
Q4
$260K Sell
5,810
-9,648
-62% -$902K 0.12% 38
2018
Q3
$34.4M Sell
15,458
-101,041
-87% -$9.34M 13.23% 1
2018
Q2
$2.84M Buy
+116,499
New +$9.73M 1.23% 13
2018
Q1
Sell
-1,216
Closed -$379K 76
2017
Q4
$379K Sell
1,216
-5,927
-83% -$475K 0.15% 62
2017
Q3
$378K Buy
+7,143
New +$593K 0.17% 61
2017
Q1
Sell
-9,016
Closed -$642K 67
2016
Q4
$642K Buy
+9,016
New +$708K 0.28% 66

Other funds holding MDT

Ashburton (Jersey)'s MDT Position: Q2 2023 in Review

Ashburton (Jersey) sold out of Medtronic (MDT) in Q2 2023, closing a stake of 3,942 shares — an estimated $2.93M sold.

Ashburton (Jersey) first reported a position in MDT in Q4 2016 and held it in 17 quarters. The position peaked at $34.4M in Q3 2018. 2,057 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

  • Ashburton (Jersey) reported no remaining Medtronic position as of Q2 2023 after selling out during the quarter.
  • Ashburton (Jersey) sold 3,942 Medtronic shares in Q2 2023, an estimated $2.93M.
  • Ashburton (Jersey) first reported a position in Medtronic in Q4 2016 and held it in 17 quarters.
  • Ashburton (Jersey)'s Medtronic position peaked at $34.4M in Q3 2018.
  • 2,057 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on Ashburton (Jersey)'s 13F filing for Q2 2023, filed 19 Jul 2023.